| Zacks Company Profile for Tandem Diabetes Care, Inc. (TNDM : NSDQ) |
|
|
| |
| • Company Description |
| Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration.
Number of Employees: 2,650 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $12.79 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 1,771,957 shares |
| Shares Outstanding: 67.57 (millions) |
| Market Capitalization: $864.21 (millions) |
| Beta: 1.45 |
| 52 Week High: $47.60 |
| 52 Week Low: $9.98 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
19.98% |
17.82% |
| 12 Week |
-37.32% |
-43.09% |
| Year To Date |
-64.49% |
-68.30% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
John F. Sheridan - President; Chief Executive Officer and Director
Rebecca B. Robertson - Chairman
Leigh A. Vosseller - Executive Vice President; Chief Financial Officer
Dick P. Allen - Director
Myoungil Cha - Director
|
|
Peer Information
Tandem Diabetes Care, Inc. (ABMD)
Tandem Diabetes Care, Inc. (DMDS)
Tandem Diabetes Care, Inc. (CPWY.)
Tandem Diabetes Care, Inc. (EQUR)
Tandem Diabetes Care, Inc. (ECIA)
Tandem Diabetes Care, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 875372203
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/05/25
|
|
Share - Related Items
Shares Outstanding: 67.57
Most Recent Split Date: 10.00 (0.10:1)
Beta: 1.45
Market Capitalization: $864.21 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.32 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-2.21 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 5.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 11/05/25 |
|
|
|
| |
